Atherosclerosis and Lipoproteins |
From Duke University Departments of Medicine (Cardiology) and Cell Biology, Duke University Medical Center, Durham, NC. Current address for K.P.: Jefferson University Center for Translational Medicine, 1025 Walnut St, Philadelphia, PA 19107.
Correspondence to Neil J. Freedman or Karsten Peppel, Box 3187, Duke University Medical Center, Durham, NC 27710. E-mail neil.freedman{at}duke.edu or karsten.peppel@jefferson.edu
Objective— Mechanisms by which tumor necrosis factor-
(TNF) contributes to atherosclerosis remain largely obscure. We therefore sought to determine the role of the arterial wall TNF receptor-1 (TNFR1) in atherogenesis.
Methods and Results— Carotid artery-to-carotid artery interposition grafting was performed with tnfr1–/– and congenic (C57Bl/6) wild-type (WT) mice as graft donors, and congenic chow-fed apolipoprotein E-deficient mice as recipients. Advanced atherosclerotic graft lesions developed within 8 weeks, and had 2-fold greater area in WT than in tnfr1–/– grafts. While the prevalence of specific atheroma cells was equivalent in WT and tnfr1–/– grafts, the overall abundance of cells was substantially greater in WT grafts. WT grafts demonstrated greater MCP-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression at both early and late time points, and proliferating cell nuclear antigen expression at early time points. Aortic atherosclerosis was also reduced in 14-month-old apoe–/–/tnfr1–/– mice, as compared with cognate apoe–/– mice. In coculture with activated macrophages, smooth muscle cells expressing the TNFR1 demonstrated enhanced migration and reduced scavenger receptor activity.
Conclusions— TNFR1 signaling, just in arterial wall cells, contributes to the pathogenesis of atherosclerosis by enhancing arterial wall chemokine and adhesion molecule expression, as well as by augmenting medial smooth muscle cell proliferation and migration.
In carotid arterial grafts implanted into apolipoprotein E-deficient mice, TNF receptor-1 deficiency reduced atherosclerotic lesion size by 2-fold. This reduction in atherosclerosis correlated with reduced arterial wall expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and MCP-1, and reduced medial SMC proliferation. TNFR1 deficiency also reduced SMC migration toward activated macrophages.
Key Words: atherosclerosis inflammation mouse models smooth muscle cells tumor necrosis factor
This article has been cited by other articles:
![]() |
Y. Yang, K. K. Parsons, L. Chi, S. M. Malakauskas, and T. H. Le Glutathione S-Transferase-{micro}1 Regulates Vascular Smooth Muscle Cell Proliferation, Migration, and Oxidative Stress Hypertension, December 1, 2009; 54(6): 1360 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kim, E.-K. Yoo, J.-Y. Kim, Y.-K. Choi, H.-J. Lee, J.-K. Kim, N. H. Jeoung, K.-U. Lee, I.-S. Park, B.-H. Min, et al. Protective Role of Clusterin/Apolipoprotein J Against Neointimal Hyperplasia via Antiproliferative Effect on Vascular Smooth Muscle Cells and Cytoprotective Effect on Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1558 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson-Ohman, G. N. Fredrikson, L. M. Nilsson-Berglund, C. Gustavsson, E. Bengtsson, M.-L. Smith, C.-D. Agardh, E. Agardh, S. Jovinge, M. F. Gomez, et al. Tumor Necrosis Factor-{alpha} Does Not Mediate Diabetes-Induced Vascular Inflammation in Mice Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1465 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kewalramani, P. Puthanveetil, F. Wang, M. S. Kim, S. Deppe, A. Abrahani, D. S. Luciani, J. D. Johnson, and B. Rodrigues AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death Cardiovasc Res, October 1, 2009; 84(1): 42 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. To, A. Agrotis, G. Besra, A. Bobik, and B.-H. Toh NKT Cell Subsets Mediate Differential Proatherogenic Effects in ApoE-/- Mice Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 671 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dol-Gleizes, R. Paumelle, V. Visentin, A.-M. Mares, P. Desitter, N. Hennuyer, A. Gilde, B. Staels, P. Schaeffer, and F. Bono Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor-Deficient Mice Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xanthoulea, M. J.J. Gijbels, I. van der Made, H. Mujcic, M. Thelen, M. N. Vergouwe, M. H.C. Ambagts, M. H. Hofker, and M. P.J. de Winther p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice Cardiovasc Res, November 1, 2008; 80(2): 309 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kavurma, N. Y. Tan, and M. R. Bennett Death Receptors and Their Ligands in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1694 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kleemann, S. Zadelaar, and T. Kooistra Cytokines and atherosclerosis: a comprehensive review of studies in mice Cardiovasc Res, August 1, 2008; 79(3): 360 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, L. Zhang, K. Peppel, J.-H. Wu, D. A. Zidar, L. Brian, S. M. DeWire, S. T. Exum, R. J. Lefkowitz, and N. J. Freedman {beta}-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration Circ. Res., July 3, 2008; 103(1): 70 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, P. Sivashanmugam, J.-H. Wu, L. Brian, S. T. Exum, N. J. Freedman, and K. Peppel Tumor Necrosis Factor Receptor-2 Signaling Attenuates Vein Graft Neointima Formation by Promoting Endothelial Recovery Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 284 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. C. Dupasquier, E. Dibrov, A. L. Kneesh, P. K. M. Cheung, K. G. Y. Lee, H. K. Alexander, B. K. Yeganeh, M. H. Moghadasian, and G. N. Pierce Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2394 - H2402. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |